Cargando…
HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer
Prostate cancer is the most common malignancy in men in developed countries. Overexpression of enhancer of zeste homolog 2 (EZH2), the major histone H3 lysine 27 methyltransferase, has been connected to prostate cancer malignancy. However, its downstream genes and pathways have not been well establi...
Autores principales: | Wang, Jianqing, He, Chenxi, Gao, Peng, Wang, Siqing, Lv, Ruitu, Zhou, Huihui, Zhou, Qidong, Zhang, Ke, Sun, Jian, Fan, Caibin, Ding, Guanxiong, Lan, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002300/ https://www.ncbi.nlm.nih.gov/pubmed/31636385 http://dx.doi.org/10.1038/s41388-019-1065-2 |
Ejemplares similares
-
HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer
por: Lu, Wei, et al.
Publicado: (2020) -
LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway
por: Wang, Jianqing, et al.
Publicado: (2018) -
ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression
por: Ding, Guanxiong, et al.
Publicado: (2021) -
EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis
por: Sun, Chenmin, et al.
Publicado: (2018) -
Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
por: Ding, Guanxiong, et al.
Publicado: (2020)